News
Recipharm secures supply of drug substance and commences manufacture of chloroquine phosphate
Recipharm, a leading contract development and manufacturing organisation (CDMO), has now secured supply of the active pharmaceutical ingredient (API) chloroquine phosphate for its drug...
Clinical Trials
Humanigen Initiates Phase III Lenzilumab Study in COVID-19
Humanigen, Inc., has dosed the first COVID-19 patient in its Phase III study for lenzilumab, its Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal...
Clinical Trials
Bioclinica Launches COVID-19 Clinical Endpoint Adjudication Solution
Bioclinica has introduced a specialized program for the adjudication of adverse events that could result from COVID-19 infection. Bioclinica's new program provides an out-of-the-box...
Press Releases
Medivant Launches Pharma Mfg. Ops in US
A new U.S.-based pharmaceutical manufacturer, Tailstorm Health, Inc., DBA Medivant Healthcare, will begin to roll out sterile single dose liquid injectable medications on the...
News
BARDA Funds Development of Tangen Biosciences Multi-Target Platform
The U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) has awarded Tangen the Second Option of a contract...
Clinical Trials
Catalent Partners with Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19
Catalent, a global leader in clinical supply services, welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its...
Clinical Trials
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read